Celldex Therapeutics Market Sentiment

Celldex Therapeutics Inc

CLDXNASDAQ

Trade with Public

$28.32

0.792.87%

Dern. MÀJ: Oct 19, 9:34 AM

$27.61

0.080.29%

Aperçu Actualités Prévisions de résultats Événements Objectifs de cours Données financièresSentimentActionnariat Comparer Options Rapport sur les stocks

Celldex Therapeutics Market Sentiment

Market sentiment signals for Celldex Therapeutics (CLDX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 16.6% short float

Options Flow▲ 0.00 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

16 analysts

Options Flow (P/C)

0.00

More calls — Bullish

1 calls · 0 puts

Avg Consensus PT

$61

+113.6%

Highest Price Target

$100

+253.1%

Guggenheim

Lowest Price Target

$34

+20.1%

Goldman Sachs

Short Interest

16.6%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 2, 2026	HC Wainwright & Co.	Joseph Pantginis—	+126.0%	$64 → $64	Maintained	Buy
Sep 23, 2026	Leerink Partners	Thomas Smith—	+210.7%	$70 → $88	Maintained	Outperform
Sep 23, 2026	Morgan Stanley	Judah Frommer—	+101.3%	$50 → $57	Maintained	Overweight
Sep 22, 2026	HC Wainwright & Co.	Joseph Pantginis—	+126.0%	$42 → $64	Maintained	Buy
Sep 22, 2026	Cantor Fitzgerald	Kristen Kluska—	+154.2%	$61 → $72	Maintained	Overweight
Sep 10, 2026	Morgan Stanley	Judah Frommer—	+76.6%	$46 → $50	Maintained	Overweight
Aug 7, 2026	Morgan Stanley	Judah Frommer—	+62.4%	$40 → $46	Maintained	Overweight
Aug 7, 2026	Barclays	Etzer Darout—	+87.1%	$48 → $53	Maintained	Overweight
Jul 29, 2026	Wells Fargo	Derek Archila—	+154.2%	$48 → $72	Maintained	Overweight
Jul 22, 2026	Wells Fargo	Derek Archila—	+69.5%	$54 → $48	Maintained	Overweight
Jul 22, 2026	Morgan Stanley	Judah Frommer—	+41.2%	$44 → $40	Maintained	Overweight
Jul 22, 2026	Cantor Fitzgerald	Kristen Kluska—	+115.4%	$67 → $61	Maintained	Overweight
Jul 22, 2026	Canaccord Genuity	Edward Nash—	+111.9%	$62 → $60	Maintained	Buy
Jul 20, 2026	Guggenheim	Yatin Suneja—	+253.1%	$90 → $100	Maintained	Buy
Jun 15, 2026	HC Wainwright & Co.	Joseph Pantginis—	+48.3%	$42 → $42	Maintained	Buy
Jun 10, 2026	UBS	David Dai—	+58.9%	$38 → $45	Maintained	Buy
May 13, 2026	Wells Fargo	Derek Archila—	+90.7%	$38 → $54	Maintained	Overweight
May 8, 2026	Barclays	Etzer Darout—	+69.5%	$45 → $48	Maintained	Overweight
Apr 20, 2026	Barclays	Etzer Darout—	+58.9%	$24 → $45	Upgrade	Underweight→Overweight
Mar 2, 2026	Goldman Sachs	Richard Law—	+20.1%	$30 → $34	Maintained	Neutral
Feb 26, 2026	Stifel	Alex Thompson—	+140.1%	$58 → $68	Maintained	Buy
Dec 17, 2025	Barclays	Etzer Darout—	-15.3%	$21 → $24	Maintained	Underweight
Nov 11, 2025	Barclays	Etzer Darout—	-25.8%	$25 → $21	Maintained	Underweight
Oct 21, 2025	Mizuho	Joseph Catanzaro—	+69.5%	$48	Initiate	Outperform
Oct 13, 2025	Barclays	Etzer Darout—	-11.7%	$25	Initiate	Underweight